{"altmetric_id":3789519,"counts":{"readers":{"mendeley":6,"citeulike":0,"connotea":0},"total":{"posts_count":1},"twitter":{"unique_users_count":1,"unique_users":["Misegurabysea"],"posts_count":1}},"citation":{"altmetric_jid":"4f6fa6103cf058f610006dd4","authors":["H Bourgeois","P Souli\u00e9","B Lucas","Blas A Mercier","A Zannetti","V Delecroix","T L'haridon","E Blot","S Delaloge","F Grud\u00e9"],"doi":"10.1158\/0008-5472.sabcs12-ot3-3-04","first_seen_on":"2015-03-15T09:31:28+00:00","issns":["1538-7445"],"journal":"Cancer Research","last_mentioned_on":1426411817,"links":["http:\/\/cancerres.aacrjournals.org\/content\/72\/24_Supplement\/OT3-3-04"],"publisher_subjects":[{"name":"Oncology And Carcinogenesis","scheme":"era"}],"scopus_subjects":["Health Sciences","Medicine","Life Sciences","Biochemistry, Genetics and Molecular Biology"],"subjects":["neoplasms"],"title":"Abstract OT3-3-04: ALOPREV: first cooling scalp trial for prevention of persisting alopecia after docetaxel for early breast cancer patients.","type":"article","mendeley_url":"http:\/\/www.mendeley.com\/research\/abstract-ot3304-aloprev-first-cooling-scalp-trial-prevention-persisting-alopecia-after-docetaxel-ear"},"altmetric_score":{"score":1,"score_history":{"1y":0,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":1},"context_for_score":{"all":{"total_number_of_other_articles":4869733,"mean":5.7965197477024,"rank":2583699,"this_scored_higher_than_pct":33,"this_scored_higher_than":1627080,"rank_type":"exact","sample_size":4869733,"percentile":33},"similar_age_3m":{"total_number_of_other_articles":146342,"mean":10.194934543293,"rank":83298,"this_scored_higher_than_pct":32,"this_scored_higher_than":46974,"rank_type":"exact","sample_size":146342,"percentile":32},"this_journal":{"total_number_of_other_articles":5586,"mean":4.8495351835273,"rank":3572,"this_scored_higher_than_pct":20,"this_scored_higher_than":1160,"rank_type":"exact","sample_size":5586,"percentile":20},"similar_age_this_journal_3m":{"total_number_of_other_articles":107,"mean":4.3014905660377,"rank":90,"this_scored_higher_than_pct":8,"this_scored_higher_than":9,"rank_type":"exact","sample_size":107,"percentile":8}}},"demographics":{"poster_types":{"member_of_the_public":1},"users":{"twitter":{"cohorts":{"Members of the public":1}},"mendeley":{"by_status":{"Student  > Ph. D. Student":2,"Student  > Postgraduate":1,"Student  > Master":2,"Lecturer > Senior Lecturer":1},"by_discipline":{"Medicine and Dentistry":5,"Nursing and Health Professions":1}}}},"posts":{"twitter":[{"url":"https:\/\/twitter.com\/Misegurabysea\/status\/577039100659822592","license":"datasift","citation_ids":[3789519],"posted_on":"2015-03-15T09:30:17+00:00","author":{"name":"Misegura","url":"http:\/\/www.misegura.nl","image":"https:\/\/pbs.twimg.com\/profile_images\/741565131679731712\/kkY9hRQ1_normal.jpg","description":"Gediagnostiseerd met (borst)kanker? Misegura streeft naar praktische oplossingen voor lastige problemen #borstkanker #prothesebikini #picclijn cover #Mimemori","id_on_source":"Misegurabysea","tweeter_id":"1448963396","geo":{"lt":null,"ln":null},"followers":356},"tweet_id":"577039100659822592"}]}}